Jane Street Group, LLC Iovance Biotherapeutics, Inc. Put Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $1.03 Million - $1.69 Million	142,100 New	142,100 $1.33 Million
Q1 2022 May 17, 2022	BUY	$12.38 - $19.1 $28,474 - $43,930	2,300 Added 3.24%	73,200 $1.22 Million
Q4 2021 Feb 15, 2022	SELL	$16.55 - $27.63 $905,285 - $1.51 Million	-54,700 Reduced 43.55%	70,900 $1.35 Million
Q3 2021 Nov 16, 2021	SELL	$20.35 - $26.63 $2.91 Million - $3.81 Million	-142,900 Reduced 53.22%	125,600 $3.1 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $3.86 Million - $7.81 Million	236,200 Added 731.27%	268,500 $6.99 Million
Q1 2021 May 18, 2021	SELL	$28.67 - $52.59 $1.16 Million - $2.14 Million	-40,600 Reduced 55.69%	32,300 $1.02 Million
Q4 2020 Feb 17, 2021	BUY	$28.04 - $50.26 $154,220 - $276,430	5,500 Added 8.16%	72,900 $3.38 Million
Q3 2020 Nov 17, 2020	BUY	$27.75 - $36.3 $88,800 - $116,159	3,200 Added 4.98%	67,400 $2.22 Million
Q2 2020 Aug 17, 2020	BUY	$27.21 - $41.0 $1.06 Million - $1.59 Million	38,800 Added 152.76%	64,200 $1.76 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $496,316 - $986,790	25,400 New	25,400 $761,000

313

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.